Biotech · Private company · Brookline, MA, US
Crimson Biopharm Inc
Track this companyFree. Adds Crimson Biopharm Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Targeting EGFR-Mutant NSCLC CNS Metastases with CM93, a Novel Brain-Penetrant EGFR InhibitorFiscal year 2026 · $1.1MNIH RePORTER 2R42CA281586-02 · fetched Nov 12, 2026